Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Sequencing of rapamycin-treated yeast strains across genetic backgrounds, with and without U18

ABSTRACT: This analysis covers the transcriptomes of four yeast strains (NA, WA, WE, and SA) under two rapamycin-based conditions: rapamycin (an autophagy inducer) alone, and rapamycin combined with U18666A (an Ncr1p inhibitor).

ORGANISM(S): Saccharomyces cerevisiae

PROVIDER: GSE315721 | GEO | 2026/01/14

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Sequencing of U18-treated yeast of different genetic background

Project description:This analysis correspond to the transcripts of four different yeast strains (NA, WA, WE, and SA) untreated and treated with the Ncr1p inhibitor U18666A

2025-02-03 | GSE286511 | GEO

Identification of rapamycin as an autophagy inducer to treat PANC-1 cells

Project description:Identification of rapamycin as an autophagy inducer to treat PANC-1 cells

| PRJNA450413 | ENA

Identification of rapamycin as an autophagy inducer to treat PANC-1 cells [miRNA]

Project description:Identification of rapamycin as an autophagy inducer to treat PANC-1 cells [miRNA]

| PRJNA450414 | ENA

GRO-seq analysis U1810 cells after 8h Rapamycin treatment and DMSO control

Project description:Investigating transcriptional changes after autophagy induction by rapamycin to compare changes in autophagy-related genes to changes in histone modifications.

2017-02-03 | E-MTAB-5490 | biostudies-arrayexpress

Transcriptome and translatome profiling of Mtb-infected human DC identifies GSK-3beta as a molecular switch of rapamycin-driven immune stimulation

Project description:In human primary dendritic cells (DC) rapamycin - an autophagy inducer and protein synthesis inhibitor - overcomes the autophagy block induced by Mycobacterium tuberculosis (Mtb) and promotes Th1 response via IL-12 secretion. Here, the immunostimulatory activity of rapamycin in Mtb-infected DC was investigated by analyzing the transcriptome and the translatome profiles. Several differentially expressed genes (DEGs) were found in transcriptome and translatome of Mtb-infected DC, showing an additional increase in presence of rapamycin, which was instead ineffective in uninfected cells. The majority of DEGs identified in the translatome resulted also present in the transcriptome-modulated genes, suggesting that both RNAs are actively translated mRNAs. The DEG in silico analysis showed significant changes in intracellular cascades related to cytokine production, cytokine-induced signaling and immune response to pathogens. In particular, rapamycin treatment of Mtb-infected DC caused a significant enrichment of IFN-beta, IFN-lambda and IFN-stimulated genes in the polysome-associated RNA fraction. In addition, IL-12, IL-23, IL-1B, IL-6, and TNF-A were induced at RNA and protein level by rapamycin in Mtb-infected DC, while IL-10 was reduced. Interestingly, upon siRNA or pharmacologically GSK-3beta inhibition, rapamycin-driven modulation of the pro- and anti-inflammatory cytokine balance was lost, thus indicating that in Mtb-infected DC GSK-3beta functions as molecular switch for the regulation of cytokine milieu. In conclusion, our study sheds light on the molecular mechanism by which autophagy contributes to DC activation during Mtb infection and highlights that rapamycin and its analogs as well as GSK-3beta modulators are promising compounds for host-directed therapy in the control of Mtb infection.

2021-04-12 | GSE163531 | GEO

Identification of rapamycin as an autophagy inducer to treat PANC-1 cells [mRNA, circRNA, lncRNA]

Project description:Identification of rapamycin as an autophagy inducer to treat PANC-1 cells [mRNA, circRNA, lncRNA]

| PRJNA450415 | ENA

Full geroprotection from brief rapamycin treatment by persistently increased intestinal autophagy

Project description:The licensed drug rapamycin has potential to be repurposed for geroprotection. A key challenge is to avoid the adverse side-effects of clinical dosing regimes. Here we show a profound memory effect of brief rapamycin treatment. Brief, early adult treatment extended lifespan in Drosophila to the same degree as lifelong dosing. Lasting memory of earlier rapamycin treatment was mediated by elevated autophagy in enterocytes of the gut, accompanied by increased intestinal spermidine levels and improved structure and function of the ageing intestine. Brief elevation of autophagy itself induced a long-term increase in autophagy. In mice, short-term, 3-month treatment also induced a full memory effect, with enhanced autophagy in Paneth cells, improved Paneth cell architecture and gut barrier function at levels induced by chronic treatment, even 6 months after rapamycin was withdrawn. Past rapamycin treatment also enhanced the regenerative potential of aged intestine in intestinal organoids. Full geroprotective effects of chronic rapamycin treatment can thus be obtained with a brief pulse of the drug.

2022-07-18 | PXD020820 | Pride

ChIP-on-Chip data from Rh30 cells +/- rapamycin treatment

Project description:p73 is a p53 family transcription factor that plays critical roles during development and tumor suppression. We analyzed p73 activity using a combination of ChIP-on-Chip and gene expression profiling, both at baseline and after treatment with the mTOR inhibitor rapamycin. We report the first comprehensive analysis of p73 binding across the genome. Furthermore, we re-analyzed this p73 cistrome after perturbation with rapamycin, an inhibitor of mTOR and inducer of p73. Multiple determinants of p73 binding, activity, and function were evident, and were modulated by mTOR.

2011-01-05 | GSE15704 | GEO

Helicase Ded1 fine-tunes the reprogramming of gene expression conferred by inhibition of TORC1 by rapamycin.

Project description:The role of Ded1 helicase is pivotal in reducing ribosomal biogenesis and inducing autophagy under TORC1 inhibition. Incorporating mutations in Ded1 rescues these effects, leading to rapamycin resistance.

2025-01-30 | GSE260591 | GEO

Gene expression analysis of human lymphoblastoid cell lines

Project description:Human lymphoblastoid cell lines (EBV-immortalised B cells, LcL) obtained from subjects of different age (young 28-40 years, centenarians >95 years) were analysed for gene expression at basal culture conditions and after 48 hours of serum starvation. Lymphoid B cells from centenarians were more resistant to apoptosis induction and displayed a more developed lysosomal compartment, the most critical component of phagic machinery. In addition, cells from centenarians were capable of engulfing and digesting other cells, i.e. their siblings (even entire cells). This behavior was improved by nutrient deprivation but, strikingly, it was unaffected by the autophagy modulating drugs rapamycin, an autophagy inducer, and 3-methyladenine, an autophagy inhibitor. 12 samples, divided into 4 groups: young basal, young starved, centenarians basal and centenarians starved.

2011-07-29 | E-GEOD-31040 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data